|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.1 CNY | +2.40% |
|
-5.81% | -31.82% |
Dali Pharmaceuticalco.,Ltd reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 73.27 million compared to CNY 100.46 million a year ago. Net loss was CNY 15.39 million compared to CNY 11.48 million a year ago.
Basic loss per share from continuing operations was CNY 0.07 compared to CNY 0.0522 a year ago. Diluted loss per share from continuing operations was CNY 0.07 compared to CNY 0.0522 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -31.82% | 246M | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
DALI PHARMACEUTICALCO.,LTD 
